Advanced Search
Contact | Corporate | Help

Daily news email for January 20, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Biotage Releases New Catalog and Technical Guide for Sample Preparation and Evaporation

Sartorius Stedim Biotech and G-Con Manufacturing Announce Global Collaboration

JSR Expands its Biomedical Business by Investing in BIA Separations' Unique Purification Technology

BrainStorm Announces Clinical Data for Safety and Supporting Efficacy of NurOwn(TM) Based on ...

AMSilk is Proud to Announce the Addition of Jeff Davis to its Advisory Board

 BioSpace
Frazier Healthcare Aims for First Biotech VC Fund After Financial Crisis

Sex Safe for Heart Patients Not Having an Extramarital Affair, Baylor College of Medicine Study

La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist; CEO Appointed

Investigators Achieve Important Step Toward Treating Huntington's Disease, University of California, Davis (UCD) Study

Amgen, Biogen Idec, Inc. (Massachusetts) Leap into Generic Drug Market

BioSpace - Breaking News
Cubist Pharmaceuticals, Inc. Reports 2011 Fourth Quarter and Full Year Financial Results

Rainbow Coral Corp. Release: Rainbow BioSciences, LLC Targets Booming Diabetes Research Market

Thermo Fisher Scientific Expands Its Popular Microdialysis Product Line

Bioindustry Support Solutions, LLC Release: STATKING Consulting, Inc. Signs Agreement to Provide Webinar Content

Data on Navidea Biopharmaceuticals's AZD4694 Presented by the Banner Alzheimer's Institute at the 6th Annual Human Amyloid Imaging Meeting (HAI)

Biotech News - Business Wire
STATKING Signs Agreement to Provide Webinar Content

Research and Markets: Emerging Medical Technologies Spotlight, A Report Of Investment & Partnering Opportunities, 2011

RBCC Targets Booming Diabetes Research Market





 Biotech News - PR Newswire
WestPark Capital, Inc. Announces $500,000 Arrogene NanoTechnology, Inc. Offering

Waters and NIBRT Complete Work on World's First UPLC Glycan Database

Boulder Diagnostics Licenses Novel Rapid Detection Technology for Homocysteine and Related Compounds from Portland State University

Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2011 Financial Results

China Health Resource Signs 3 Year Exclusive Agreement for Acquisition of Gastrodia Extending Very Successful Product Line Through 2015
Biotechnology - Moreover
Plethora wins product license

ZeaChem Advances First Multi-Product Biorefinery C2-Chain Process Testing Gets Underway

Worldwide Laboratory Automation Market to Reach US$4.1 Billion by 2015, According to New Report by Global Industry Analysts, Inc.

Start-ups saw big rise in funding during 11

EU agency issues guideline on biosimilar MS drugs (Reuters)

 Burrill Report
The February 2012 Issue of The Burrill Report

Novartis to Ax 2,000 jobs after Tekturna Development Halted

Genentech Partners with Xenon Pharmaceuticals in $646M Pain Pact

Forma Therapeutics Inks Alliance with Janssen Biotech

Bristol-Myers Squibb Buys Inhibitex for $2.5 Billion

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Perfusion Products

Au vu des résultats positifs d'une analyse intermédiaire le Comité indépendant de surveillance et de sécurité de l'étude clinique FAME II de St. Jude Medical recommande l'arrêt des inclusions

Samenvatting: De FAME II onafhankelijke Data Safety Monitoring Board (DSMB) beveelt St. Jude Medical een patiënten opnamestop aan voor de FAME II clinische trial na een positieve tussen analyse.

Resumen: Sapheon anuncia los resultados en humanos después de un año; comienza la inscripción para estudio europeo de postventa

Research and Markets: Inflammation Global Clinical Trials Review, H2, 2011

 Clinical Trials - PR Newswire
Insmed Incorporated Provides Corporate Update

INVO Bioscience Announces Approval of INVOcell by Brazil's ANVISA

Carnegie Mellon University Study Reveals Potential of Manganese in Neutralizing Deadly Shiga Toxin

Combination of Oral Drugs Suppresses Common Type of Hepatitis C, According to University of Michigan-led Research

BioElectronics' Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery

 CNN Top Stories
Opinion: Santorum was real winner

GOP candidates make final push in S.C.

Singer Etta James dies at 73

Georgia child killer found dead in prison

6 Marines, 4 French killed in Afghanistan
Contract Pharma
Genzyme, Veracyte in Global Co-Promotion Pact

Unicep Names Program Management Director

Alnylam Restructures, Cuts 33% of Workforce

Frontage Labs Achieves CMC Milestone

Suzhou Pharma Services Appoints President

 FDA Drugs- What's New
Medication Guides

FDA Drug Safety Communication: New Boxed Warning and Contraindication for Adcetris (brentuximab vedotin)

FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82

FDA Statement on recently terminated clinical trial with Doribax (doripenem)

Questions and Answers: FDA approves a class Risk Evaluation and Mitigation Strategy (REMS) for transmucosal immediate-release fentanyl (TIRF) medicines

 FDA News - Business Wire
La U.S. Food and Drug Administration approuve de nouvelles formulations de Viread® pour les enfants infectés par le VIH

U.S. Food and Drug Administration keurt nieuwe formuleringen van Viread® goed voor gebruik door kinderen met hiv

US-Arzneimittelbehörde FDA genehmigt neue Rezepturen für Viread® zur Anwendung bei HIV-infizierten Kindern

Perfect Image Solutions, LLC Issues Voluntary Recall of Unapproved Product Due to Potential Health Risk

LAgenzia per gli Alimenti e i Medicinali statunitense (Food and Drug Administration, FDA) approva delle nuove formulazioni di Viread® per luso in bambini con infezione da HIV
FDA Press Releases
FDA approves Voraxaze to treat patients with toxic methotrexate levels

FDA to protect important class of antimicrobial drugs for treating human illness

FDA: Chicago-area sandwich manufacturer agrees to stop production

FDA expands use of HIV drug Isentress to children and adolescents

FDA: Do not use ShoulderFlex Massager

 FDA Vaccines, Blood and Biologics - What's New
Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

Fluzone, Fluzone High-Dose and Fluzone Intradermal

 FierceBiotech
Sanofi CEO challenges FDA to clear up regulatory pathway for new meds

Alnylam cutting third of jobs to devote cash to lead RNAi programs

Amgen, Biogen jump into copycat game amid string of biosimilars deals

4SC surges on positive midstage data for advanced liver cancer

Animal rights activists boiling mad at BMS
FierceBiotech IT
Medidata chief calls company 'the cloud' for clinical data

AB Sciex, Indigo BioSystems join forces on mass spectrometry software

DecisionView updates clinical trial enrollment software

Entelos stages comeback bid with funding

PerkinElmer CEO arranges marriage between informatics, lab service biz

 FierceBiotech Research
Obama seeks to beat Alzheimer's by 2025

Altering intestinal bacteria with probiotics improved rats' heart health

Sugar molecules betray precancerous cells in esophagus

PARP inhibitors could aid larger ovarian cancer patient population

Vitamin D helps (more than) 3 (nearly) blind mice see

 FiercePharma
Can AstraZeneca continue to swear off major M&A

New death reports prompt EMA review of Gilenya

Pharma gets its close-up in new Hollywood films

UPDATED: J&J said to settle TX Risperdal case for $158M

AZ chief: Emerging markets are tougher than you think
FiercePharma Manufacturing
Toray takes stake in Mitsui bio-CMO

Genzyme revives Fabrazyme with EMA plant OK

Lean earns Lundbeck big prize, cost cuts

Bioprocess budget hikes a sign of efficiency quest

Novartis, Lundbeck score wins for manufacturing in the West

 FierceVaccines
Confident Inovio chief pushes ahead on universal flu vaccine

Paragon nabs $15M filovirus vax contract from DoD

Scientists balk as U.S. gov't pushes limits to bird flu discourse

Breast cancer vaccine set for large-scale testing

Flu season gets off to a sluggish start

 Health News - BizJournals.com
North Carolina slapped with 'F' on smoking cessation programs

Guilford commissioners approve Solstas incentives

Details of Prince George's hospital plan delayed until March

Allos Therapeutics gets negative opinion from Europe

Outpatient surgery boosts revenue at Sarasota Memorial
Health News - CNBC
Elections loom as big variable for health insurers

Ziopharm Oncology prices sale of 9.7M shares

Novartis drug investigated after 11 deaths

Sequenom expects to raise $54M from stock sale

More labs close to deadly bird flu mutations: researcher

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
Capstone Therapeutics Drops Drug Development due to Pending Whistle-Blower Law Suit

Biopharma Investment Grows During Q4 but VCs Fund Fewer Early Deals

GEN Poll Voters Divided on Prospects for Growth of Emerging Bioclusters

Quintiles Takes Majority Stake in Oxford Cancer Biomarkers

Bayer Plans 2012 Filing for Regorafenib Following Positive Phase III mCRC Trial Results
Marketwire - Pharma and Biotech
'Listen. Write. Present' Offers Communication Tips for Science Professionals

Frost & Sullivan Lauds Symrise for Its Unique Eyelash Enhancing Offering -- SymPeptide(R) 226 EL

mscripts(TM) Mobile Pharmacy Application Platform Adds Shopping Features and Family-Friendly Prescription Management

Signature Diagnostics to Present a novel Companion Diagnostic Product Predicting Response to Cetuximab in Colorectal Cancer at the ASCO 2012 Gastrointestinal Cancer Symposium in San Francisco

Signature Diagnostics to Present Detector C 2.0 - A Blood Test for Early Detection of Colorectal Cancer at the ASCO 2012 Gastrointestinal Cancer Symposium in San Francisco

 MassBio News
451 Marketing & Freeman to Create Massachusetts Pavilion at 2012 BIO International Convention

Local students explore Biotech Futures

A Note from the President: Looking Forward to a Busy 2012 at MassBio

BIO International Convention Returning to Boston in 2012

The Blogs MassBio Reads

 Medical Pharma - PR Newswire
The Zacks Analyst Blog Highlights: GileadSciences, Bristol-Myers Squibb, Inhibitex, Vertex Pharmaceuticals and Merck

National Wire & Cable Launches XRF Materials Quality Verification System

CareFusion Provides Update on Voluntary Recall of Neurological Monitoring Software and Devices

Bestnet A/S Donates Netprotect® LLINs in Support of the JCI/Nothing But Nets Campaign

Genomic Health Presents Results From First Clinical Decision Making Study of Oncotype DX® Colon Cancer at the 2012 Gastrointestinal Cancers Symposium
National Center for Biotechnology Information
GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

SRA News

 Nature Biotechnology
Approval on a knife edge

Bringing business risk into sharp focus

The NIH's role in accelerating translational sciences

Building stem-cell genomics in California and beyond

Foundation Medicine

 New York Times- Biotechnology
Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

Drew Endy: Better Computing for the Things We Care About Most

DNA Sequencing Caught in Deluge of Data

China’s New Economic Plan Focuses on Raising Standards of Living
New York Times- Pharmaceuticals
F.D.A. Delays Approval of New Diabetes Drug

Johnson & Johnson Settles Risperdal Claim in Texas

Helping Injured Dogs Walk Again

Pill Organizers Pretty Enough to Come Out of the Cabinet

U.S. to Tell Drug Makers to Disclose Payments to Doctors

 OnBioVC
Monteris Medical, Inc.: Series C $8.6M

Sorbent Therapeutics, Inc.: Series B

OnBioVC: End Piracy, Not Liberty

Verastem, Inc.: Series B $32M

Transcend Medical, Inc.: Series B $16M

 Outsourcing-Pharma
Parexel discusses transdermal drug delivery techs

Sponsors and CROs differ on perception of service quality, says the Avoca Group

Recipharm CEO talks CMO sector recovery and Asian plans

Covance adding mass spec for biosimilars

Embedded service providers are future of the industry, says RPS
Pharma News - Business Wire
Research and Markets: Pharmaceutical M&A in the Asia Pacific Region: a Datamonitor report

Research and Markets: AIDS-Related Opportunistic Infections - Pipeline Review, H2 2011

Anderson Packaging Receives 2011 Illinois Performance Excellence (ILPEx) Silver Award for Progress Toward Excellence

Medgenics' Receives Allowance for Key European Patent

Sarah Cannon Research Institute to Present at ASCO Gastrointestinal Cancers Symposium

 Pharma News - PharmiWeb
New study finds ICT investments could cut healthcare costs for key ailments by more than 35%

Vitamin World(R) Raises Over $545,000 in 2011 for Vitamin Angels

Specialty Healthcare Services Provider, IntegraMed America to Host Q4 Conference Call Thursday, February 16th at 10:00 A.M. ET

Bestnet A/S Donates Royal Blue and Gold Striped Netprotect® LLINs to Rotary in Cote d'Ivoire

Beremans Ltd announces publication of Melanoma: Interventional clinical trials activity 2006-2011.

 Pharma News - PR Newswire
Utilizing Marketing Innovations to Engage with Customer Groups that are Key to the Pharmaceutical Industry

USAID Partners with Batey Relief Alliance to Combat Hunger in Haiti and Dominican Republic

Allscripts to Announce Fourth Quarter and Full Year 2011 Financial Results on February 16

Berkery Noyes Releases 2011 Pharma & Healthcare Information and Technology Industry Mergers & Acquisitions Report

Pharmacists Ask Medicare to Help Seniors Complaining About Inadequate Pharmacy Access in Medicare Prescription Drug Plans
Pharmaceutical - Moreover
Ono Pharmaceutical Company Chooses Medidata Rave for Its Enterprise EDC/CDM Solution [Health & Beauty Close - Up]

Demand to rise by 8% per year to USD 5.1 bn in 2015 / Pharmaceutical market dominates applications / Beverage gains driven in part by drive to replace BPA / Freedonia reports

La Jolla Pharmaceutical Picks Up Solana's Galectin-3 Antagonist

LA JOLLA PHARMACEUTICAL COMPANY: Acquires gcs-100, a first-in-class galectin-3 anatagonist

Use of 12-Month Renal Function and Baseline Clinical Factors to Predict Long-Term Graft Survival: Application to BENEFIT and BENEFIT-EXT Trials

 PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

 PRWeb - Biotechnology
International EECP Therapists Association Announces International...

Make 2012 Your Breakthrough Year: 12 Reasons to Switch to DNA2.0 in...

Dr. Endre Selmeczy's Tri-Valley Mercury Free Dentistry Office Now...

The Tri-Valley Sedation Dentistry Office of Dr. Endre Selmeczy...

LegUp LandinGear Releases New Instructional Video
PRWeb - Pharmaceuticals
Worldwide Laboratory Automation Market to Reach US$4.1 Billion by...

NextGen Sciences Launches its 82 Protein Cerebrospinal Fluid (CSF) CNS...

Absorption Pharmaceuticals to Attend Urological Conference with Its...

US Drug Watchdog Now Shifts Their Focus To Compensation & The Best...

New Study Finds Osteoporosis Progresses Slowly; Questions Need For...

 Scientific American
Catching a Gravity Wave: Canceled Laser Space Antenna May Still Fly

Solar Swan Song: NASA Satellite Witnesses a Comet's Plunge into the Sun

Genetically Engineered Stomach Microbe Converts Seaweed into Ethanol

Dirty Dancing: Dung Beetles Get Down to Walk the Line

Rainforest in Transition: Is the Amazon Transforming before Our Eyes

 Sports - ESPN Basketball
Saint Mary's remains undefeated in WCC play

Penn State survives late to upset No. 25 Illinois

Barnes fuels 19-0 run as Tar Heels down Hokies

No. 17 Virginia bounces back, pounds Ga. Tech

Morgan St. coach Bozeman reinstated by school
Sports News - ESPN
Yale tightens tailgating rules after woman killed

Penn St. trustees hope to address alumni angst

Former Michigan receiver enters not guilty plea

Ala. man seen in lewd post-BCS video arrested

Gundy wins Bryant Award as top college coach

 Xconomy Life Sciences
In Life Sciences Partnerships, You Must be Smart from the Beginning

Millennium, Looking to Fend Off Onyx, Eagerly Awaits FDA Word on New Velcade

Clarus Ventures Looks to Steer Ship Through Less Predictable Biotech Seas

San Diego VC Activity at Ebb Tide in 2011 and Top 10 Local Deals

Xconomist of the Week Chris Rizik: Who Says A VC Has No Soul

 Yahoo Biotech News
EU agency issues guideline on biosimilar MS drugs (Reuters)

Genes Important to Keep Brain Sharp Through Old Age (LiveScience.com)

Genes May Guide Intelligence Throughout Life (HealthDay)

Genes May Give Clues to Severe Form of Lupus (HealthDay)

BrainStorm sees positive data in ALS stem cell trial (Reuters)


SourceSolution © 2008-2012